Aster DM Healthcare Ltd consolidated net profit of Rs20.35cr in Q1FY19, vs net loss of Rs80.04cr in Q1FY18 : Beats Estimates

The company’s consolidated revenue stood at Rs1,774.65cr, up 14.02% yoy but down 0.54% qoq.

Aug 16, 2018 04:08 IST India Infoline Research Team

Aster DM Healthcare Ltd Q1FY19

Consolidated Results Q1FY19: (Rs. in cr)

Q1FY19 YoY (%)
Revenue 1,774.65 14.0
EBITDA 123.92 211.1
EBITDA Margin (%) 7 442
Net Profit (adjusted) 20.35 0
***EBITDA margin change is bps
Aster DM Healthcare’s revenue in Q1FY19 grew by 14% yoy to Rs1,774.7cr. EBITDA in Q1FY19 grew by 211.1% yoy to Rs123.9cr vs. Rs39.8cr in Q1FY18 and Rs263.1cr in Q4FY18. EBITDA margins grew by 442bps yoy to 7% in Q1FY19 vs. 2.6% in Q1FY18. Company reported a PAT of Rs20.4cr in Q1FY19 vs. loss of Rs80cr in Q1FY18.
  • Revenues from hospital segment increased by 17% yoy to Rs897cr in Q1FY19 from Rs763cr in Q1FY18. This performance was driven by addition of new specialties, services and increase in beds.
  • EBITDA from hospital segment increased 184% yoy from Rs38cr in Q1FY18 to Rs108cr in Q1FY19, EBITDA margin stood at 12% in Q1FY19 vs. 5% in Q1FY18.
  • Revenues from clinics grew by 11% yoy to Rs453cr in Q1FY19 from Rs410cr in Q1FY18 due to new clinic set ups and higher footfalls.
  • EBITDA from clinics grew 59% yoy from Rs34cr in Q1FY18 to Rs54cr in Q1FY19, EBITDA margin stood at 11.8% in Q1FY19 vs. 8.3% in Q1FY18.
  • Revenues from pharmacy segment increased by 20% yoy to Rs472cr in Q1FY19 from Rs394cr in Q1FY18.
  • EBITDA in the pharmacy segment increased 16% yoy to Rs29cr in Q1FY19 vs. Rs25cr in Q1FY18. The EBITDA margin was at 6.1% in Q1FY19 compared to 6.2% in Q1FY18.




Technical View:

Aster DM Healthcare Ltd is currently trading at Rs. 179.50, up by 10.55 points or 6.24% from its previous closing of Rs. 168.95 on the BSE.
The scrip opened at Rs. 175 and has touched a high and low of Rs. 180 and Rs. 170.80 respectively. So far 89,293 (NSE+BSE) shares were traded on the counter. The stock is currently trading below its 100 DMA.

Related Story